Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (29360)	11/7/1999 3:01:00 PM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

interesting read about leptin in LA Times today I thought i?d share... link is latimes.com story fragementeded below BOSTON--Last month, the Journal of the American Medical Assn. reported that leptin, a hormone discovered five years ago by Rockefeller University researcher Jeffrey M. Friedman, is not the weight-loss panacea once hoped. Some will no doubt regard this finding as yet another disappointing setback in the effort to make sense of the obesity epidemic. But the announcement might more accurately be seen as evidence of how far we have come in understanding what was a totally baffling conundrum: why so many have lost the battle to achieve and maintain a healthy weight. Like all good science, the study of the genetics of obesity has proceeded in fits and starts, with success building on a foundation of failure. That leptin is not an easy cure for corpulence may have dashed unrealistic dreams of a magic bullet, but the identification of leptin and the gene that regulates it have lead to a radical new understanding of weight control. The discovery of leptin offered the first tangible evidence of a theory, long held by Friedman and a handful of other researchers, that the regulation of eating behavior is, at its heart, genetic, that people act on biologically wired drives and that the intensity and duration of these drives vary with individual brain chemistry. This finding represents a remarkable breakthrough in the understanding of human disease and bolsters a controversial theory of human psychology. It offers irrefutable support for evolutionary biologist Edward O. Wilson's once radical theory that genes can act directly to mold behavior; in this case, the highly complex and culturally laden behavior of eating. It is also evidence that this complex behavior can be modified and controlled through manipulation of an intricate pathway in the brain. With hundreds of researchers around the world exploring the molecular pathway the discovery of leptin blazed, it is only a matter of time--and perhaps not much time--before a true understanding of what underlies the nation's growing collective girth emerges. While the laws of physics dictate that fat people eat more and/or exercise less than do thin people, the laws of genetics determine who among us will be driven to eat too much. This is not to suggest that genetics is destiny: We all know people who have the vigilance to overcome their biology. But for a burgeoning number of us, the tug of genetics has become irresistible. This is why most weight-loss programs fail, even for people whose very lives depend on them. It is why obesity-linked gall bladder disease, cardiovascular disease, hypertension and cancer are skyrocketing. One in two Americans are overweight, and nearly one in five is obese: more than 30% are above their ideal body weight. Nineteen million Americans, including 20% over age 60, have obesity-linked diabetes. But even these statistics can't begin to describe the damage that being overweight wreaks on our media-driven self-esteem. It is sobering to consider that "Baywatch," which portrays a world in which being slim is not optional, is the most popular television series on the planet. What is known is that obesity is one among a group of particularly intractable disorders, including heart disease, diabetes and hypertension, that arise not from purely genetic causes, or from environmental influences, but from a complex [Image]interaction of both. Most modern-day scourges for which there are no good treatments are the consequence of this interaction. Attempts to control and curb the environmental influences on obesity have largely failed because they underrate the power of human nature: McDonald's McLean lasted only long enough to whet appetites for Burger King's Triple Whopper. The discovery of leptin allowed scientists to see for the first time the underlying forces driving this hunger--that is, why so many of us eat more than is good for us. It was the defining event that transformed obesity research from a largely third-rate, speculative backwater to a viable scientific inquiry. The once-popular notion that common obesity was the result of some "glandular irregularity" or gross metabolic defect was largely laid to rest, as were psychological theories that blamed excess pounds on gluttony or a weakness of will. It became clear why generation after generation of diet drugs, some of them dangerous, had in the long run proved ineffective, and why so few are able to stick to the sensible, low-calorie diet regimens prescribed by talk-show hosts, glossy magazines and well-meaning friends. It has become clear to even the most skeptical of scientists that the key to effective weight control is genetic understanding. After the publication of Friedman's discovery in a cover story in the journal Nature, hundreds of millions of dollars poured in to support research into the genetics of weight regulation. More than 800 papers on leptin were published in three years, research that lead scientists to conclude that the hormone is at the hub of a labyrinthine system that precisely

To: bob zagorin who wrote (29360)	11/8/1999 3:43:00 PM
From: J Stone	Read Replies (1) \| Respond to of 32384

Price strength is continuing to build. With the LGND hitting 9 and LGNDW hitting 3, my model is totally at a loss for projecting movements with resistance points. However, I believe this pattern is reminiscent of a year ago as the price gathered strength prior to the expected FDA rulings on Panretin and ONTAK. If Targretin capsules get a clean approval from the FDA, it should create a strong resistance floor for the stock. Anyone know anything about the ABC trials? Jeff